home.social

#neuroscience — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #neuroscience, aggregated by home.social.

  1. DATE: November 15, 2026 at 07:32PM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: An ancient virus may help explain what makes the human brain different

    URL: sciencedaily.com/releases/2026

    A virus that infected chimpanzees millions of years ago may have helped shape one of the most important differences between humans and our closest relatives: how our brains develop. Scientists at Lund University discovered that ancient viral DNA embedded in the chimpanzee genome switches off a gene called LINC00662, which remains active in humans and appears to play an important role in early brain development.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #HumanBrain #BrainDevelopment #AncientVirus #ViralDNA #HumanEvolution #Chimpanzees #Genetics #Neuroscience #EvolutionaryBiology #ScienceNews

  2. DATE: November 15, 2026 at 07:00AM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: Common genetic variants matter more in Alzheimer’s than scientists thought

    URL: psypost.org/common-genetic-var

    An international genetic study of more than 2.8 million people has identified 127 regions of human DNA associated with Alzheimer’s disease, including 48 regions linked to the condition for the first time.

    Published in Nature, the research indicates that common inherited variants account for nearly three times as much of the population variation in Alzheimer’s risk as previous estimates suggested. The findings also connect genetic susceptibility to heightened gene activity in brain immune cells alongside dampened gene activity in nerve cells.

    Searching for Missing Genetic Risk in Alzheimer’s Disease

    Alzheimer’s disease is a progressive brain disorder that gradually erodes memory, reasoning, and everyday functioning, accounting for most dementia cases worldwide. Existing disease-modifying drugs mainly aim to remove sticky clumps of amyloid-beta protein from brain tissue, yet they tend to offer modest symptom relief. Because twin studies indicate that inherited differences account for 60% to 80% of the variation in Alzheimer’s risk, researchers use genome-wide association studies, scanning millions of common single-letter DNA variations across populations to find chromosomal regions, called loci, linked to the illness.

    Larger samples have steadily expanded that map. For example, a 2021 genetic study of more than 1.1 million people was led by several of the same researchers, including co-lead author Douglas Wightman, and shared several cohorts with the new work. That analysis uncovered seven new risk regions and highlighted microglia, the specialized immune cells in the brain and spinal cord that engulf debris and respond to injury. Soon after, a 2022 genome-wide study of nearly 790,000 individuals, which also shared several co-authors and datasets with the current study, mapped 75 risk regions and brought the total number of known Alzheimer’s loci to roughly 80.

    Even with dozens of risk regions mapped, statistical tallies of heritability suggested that common DNA variants explained only about 5% of population differences in risk, fueling doubts that much genetic risk remained to be found beyond APOE, a major risk gene that transports cholesterol and fats in the brain. The authors of a 2020 genetic modeling study argued that late-onset Alzheimer’s might involve fewer than 100 common causal variants in total, implying gene discovery had nearly plateaued.

    Other models predicted roughly 1,200 contributing regions, prompting study co-lead authors Emil Uffelmann and Douglas P. Wightman, researchers in the Complex Trait Genetics lab at Vrije Universiteit Amsterdam, and their colleagues to test how much common genetic risk remained hidden.

    “The main goal of our study was locus discovery: identifying variants and genes that affect the risk of developing Alzheimer’s disease,” Uffelmann told PsyPost. “Each new discovery provides clues about the causes of the disease and may lead to new treatments in the future. Another, more academic, motivating factor was to address the conundrum of low heritability estimates.”

    Mapping 127 Genetic Regions Across 2.8 Million People

    The team pooled data across 30 cohorts totaling more than 2.8 million participants: 109,479 diagnosed Alzheimer’s cases, 74,141 proxy cases, 2,131,799 controls, and 499,708 proxy controls. Because Alzheimer’s typically emerges after age 65, many biobank volunteers are too young to show symptoms, so genotyped adults who reported a parent with Alzheimer’s or dementia served as proxy cases, weighted to reflect the half of parental DNA that children inherit.

    Measured by effective sample size, which weights cohorts by their balance of cases and controls, the dataset was 91% European, 5% African, 3% East Asian, and under 1% each of admixed American and South Asian ancestry.

    Across the cohorts, the team analyzed more than 8.1 million common DNA variants, adjusting for age, sex, genetic ancestry, and study-specific factors while excluding cases diagnosed before age 40 where possible to avoid rare single-gene forms of the disease. Researchers then combined the genetic map with machine-learning tools, single-cell brain RNA atlases, and regulatory drug databases to identify likely causal genes, relevant cell types, and drug interactions. Analysis code and summary statistics, excluding proprietary 23andMe data, were posted publicly.

    Across all meta-analyses, the researchers identified 127 distinct genetic regions associated with Alzheimer’s disease, consisting of 118 in the multi-ancestry analysis and nine additional regions in the European-only analysis. Forty-eight regions were newly identified, while associations on the X chromosome, tested in a smaller effective sample of 196,822 compared with 416,493 overall, were not statistically significant. Ancestry-specific scans detected 114 regions in European, three in African, and two in East Asian groups, whereas associations in the smaller South Asian and admixed American samples were not statistically significant.

    A subset with direct clinical diagnoses rather than parental proxies included 20,402 female cases and 15,689 male cases, with 261,889 and 214,956 controls respectively. Inherited risk overlapped closely between men and women. However, the high-risk ε4 variant of APOE carried a modestly stronger association with Alzheimer’s disease in women than in men, about 13% stronger.

    Microglial Overactivity and Neuronal Dampening

    Comparing the genetic findings against single-cell RNA data from donated brain tissue showed that genetic risk concentrated in genes expressed at higher levels in microglia and lower levels in neurons, the nerve cells that transmit electrical and chemical signals across the brain, in people with Alzheimer’s compared with unaffected donors. Three neuronal subtypes initially stood out, including two types of inhibitory, or signal-braking, neurons that produce somatostatin or small signaling peptides and are known to be vulnerable early in Alzheimer’s. After adjusting for average expression changes across all brain cell types, however, the microglial link held firm while the individual subtype signals weakened, indicating broader neuronal dampening.

    The authors suggest that inherited risk variants may push microglial immune genes toward overactivity while lowering gene expression in vulnerable neurons, though they note it remains uncertain whether neuronal dampening is an initial trigger or a downstream consequence of pathology. Pathway analyses reinforced roles for immune activation, fat binding, cell adhesion, and amyloid clearance, alongside five processes new to Alzheimer’s genetic scans, including oxidative-stress regulation via glutathione metabolism and membrane recycling at nerve junctions.

    Higher Heritability and Sharper Risk Prediction

    Using a statistical model that accommodates APOE’s large impact alongside functional DNA features, the team estimated that common variants account for 16% of population differences in underlying susceptibility to Alzheimer’s among people of European ancestry, assuming a 5% lifetime prevalence. That heritability estimate is nearly triple the 6% figure from an older regression method that simulations indicated understates heritability when one gene dominates, while African-ancestry heritability estimates were not statistically significant given smaller samples and greater genetic diversity.

    Combined into a polygenic score, a single number summarizing inherited risk across millions of DNA variants, the predictors explained nearly 13% of the variation in disease susceptibility on average across held-out European cohorts, outperforming APOE status alone. Among European-ancestry UK Biobank adults aged 65 and older, Alzheimer’s prevalence was seven times higher in the top 10% of polygenic scores than in the bottom 10%, and three times higher than the whole-sample average.

    Uffelmann offered a sharper version of the same comparison: “Thinking about genetic risk in absolute terms may be useful. We found that, on average, 1 in 20 participants aged 65 years or older in the UK Biobank were diagnosed with Alzheimer’s disease. In people with the highest genetic risk (top 1%), the fraction of Alzheimer’s cases increased to almost 1 in 4. Clearly, genetics plays an important role in affecting risk, but it does not determine diagnosis.”

    Potential Drug Targets and Shared Brain Pathways

    Cross-referencing newly prioritized genes with regulatory databases identified 17 genes in the new regions that interact with approved non-Alzheimer’s medications. Compounds targeting three of those genes showed promise in earlier animal studies of Alzheimer’s, whereas drugs targeting two others failed to ease symptoms in prior mouse or human tests.

    Within a known risk region, the team’s model newly prioritized QPCT, which encodes an enzyme that modifies amyloid-beta into the specific form targeted by the approved Alzheimer’s antibody drug donanemab. A newly identified region spanning UBE2V1 and SPATA2, genes involved in protein clumping and programmed cell death, had previously been linked to both amyotrophic lateral sclerosis and frontotemporal dementia, and shared a likely causal variant between Alzheimer’s disease and amyotrophic lateral sclerosis.

    These results align with an earlier multi-ancestry genetic analysis of clinically diagnosed and family-history cases, which uncovered 16 novel Alzheimer’s risk regions and linked several to altered brain gene expression. The cellular pattern also echoes an earlier post-mortem brain tissue study. Although that work measured active gene expression after death rather than inherited DNA variants across populations, it similarly pointed to heightened inflammatory activity in microglia paired with reduced signaling gene expression in neurons in Alzheimer’s disease.

    Caveats and the Bigger Health Picture

    There are a few things to keep in mind when interpreting these findings. Although public and nonprofit grants primarily funded the work, several co-authors are employed by or hold stock in pharmaceutical and biotechnology companies, including Roche, Regeneron, Amgen deCODE genetics, Janssen, Bayer, and Eli Lilly, which makes donanemab. Co-author Kaj Blennow became an Eli Lilly employee in September 2025. Several other authors have served as paid consultants or advisors to drugmakers developing Alzheimer’s treatments.

    More than 90% of the effective sample also came from people of European descent, which limited locus discovery in underrepresented groups and made polygenic scores far less accurate in African and East Asian cohorts. Roughly 40% of all cases, and 62% to 82% in non-European groups, relied on self-reported parental dementia history rather than clinical diagnoses, potentially blending Alzheimer’s with other late-life dementias. Finally, a genetic link or drug-database match does not mean targeting a gene will safely slow cognitive decline, and polygenic scores remain probabilistic estimates rather than diagnoses, pointing to the need for laboratory experiments and more diverse clinical cohorts.

    Stepping back, Uffelmann emphasized that inherited DNA is one piece of a broader health picture. “Genetics plays an important role in Alzheimer’s risk and points mostly to immune involvement, chiefly through microglia, the brain’s resident immune cells,” he said. “Yet it’s only part of the story, and lifestyle and environmental factors also matter.”

    The study, “Alzheimer’s disease genetics converges on microglial and neuronal dysregulation,” was authored by Emil Uffelmann, Douglas P. Wightman, Shahram Bahrami, Alexey A. Shadrin, Vera Fominykh, Takafumi Ojima, Chenyang Jiang, Christian Benner, Elisa Moreno, Adrian I. Campos, Jesper Q. Thomassen, Emmanuel Minois-Genin, Hei Man Wu, G. Bragi Walters, Richard Sherva, Tian Lin, Xuemin Wang, Julien Bryois, Kristi Krebs, Marijn Schipper, Akira Narita, Alessandro Serretti, Anja H. Simonsen, Anna L. van Seumeren, Anne Corbett, Anne-Brita Knapskog, Annette M. Hartmann, Anouk den Braber, Argonde C. van Harten, Arvid Harder, Arvid Rongve, Bengt O. Madsen, Betty M. Tijms, Bitten Aagaard, Bjørn Lichtwarck, Bjørn-Eivind Kirsebom, Byron Creese, Chandra A. Reynolds, Sara Hägg, Ida K. Karlsson, Christian Erikstrup, Christina Mikkelsen, Clive Ballard, Dag Aarsland, Daichi Shigemizu, Dan Rujescu, Daniel Gudbjartsson, Eivind Aakhus, Erik Sørensen, Eystein Stordal, Flora H. Duits, Frank J. Wolters, Frederic Blanc, Geert Jan Biessels, Geir Selbæk, Geir Bråthen, Gen Tamiya, Gunhild Waldemar, Harro Seelaar, Helga Eyjolfsdottir, Henne Holstege, Henning Bundgaard, Henrik Zetterberg, Henrik Ullum, Ina Giegling, Ingmar Skoog, Ingrid T. Medbøen, Ingvild Saltvedt, Irena Rektorova, J. Michael Gaziano, Jan Haavik, Jens Hjerling-Leffler, Jiao Luo, Jon Snaedal, Everard G. B. Vijverberg, Julia M. Sealock, Kaj Blennow, Kaja Nordengen, Karin Persson, Katja Scheffler, Koichi Matsuda, Kouichi Ozaki, Lasse Pihlstrøm, Lavinia Athanasiu, Lene Pålhaugen, Marc Hulsman, Margda Waern, Maria Averina, Marianne Wettergreen, Marta R. Moksnes, Martijn Huisman, Masayuki Yamamoto, Mathias Toft, Matthew S. Panizzon, Mie Topholm Bruun, Mohsen Ghanbari, Monique Franc, Nancy L. Pedersen, Nathaniel Y. Bell, Niccoló Tesi, Ole B. Pedersen, Oleksandr Frei, Olivier Bousiges, Per Svenningsson, Pieter J. Visser, Qingqin S. Li, Richard Hauger, Rui Zhang, Shinichi Namba, Sigrid B. Sando, Silke Kern, Srdjan Djurovic, Steinunn Thordardottir, Tanya N. Phung, Thomas Truelsen, Thomas Werge, Thomas F. Hansen, Tomoki Kyosaka, Torgeir Engstad, Tormod Fladby, Victoria Merritt, Sverre Bergh, Wiesje M. van der Flier, Rujin Wang, Eli A. Stahl, Basavaraj Hooli, LifeLines Cohort Study, DBDS Genomic consortium, Regeneron Genetics Center, Penn Medicine Biobank, GHS-RGC DiscovEHR collaboration, Mayo Clinic-RGC Project Generation, Colorado Center for Personalized Medicine-RGC Collaboration, UCLA-RGC ATLAS collaboration, INDIANA-CHALASANI, Mount Sinai Million Health Discoveries Program, Estonian Biobank research team, VA Million Veteran Program, Lea K. Davis, Mark W. Logue, Kelli Lehto, Anna Zettergren, Ben M. Brumpton, Jian Zeng, Peter M. Visscher, Paul F. O’Reilly, Anubha Mahajan, Manuel Ferreira, Yukinori Okada, Sven J. van der Lee, Sisse R. Ostrowski, Ruth Frikke-Schmidt, Hreinn Stefansson, Karl Heilbron, Ole A. Andreassen, and Danielle Posthuma on behalf of the Alzheimer’s Disease Working Group of the Psychiatric Genomics Consortium.

    URL: psypost.org/common-genetic-var

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AlzheimersDisease #AlzheimersResearch #Genetics #GeneticResearch #BrainHealth #DementiaResearch #Neuroscience #Microglia #PrecisionMedicine #MedicalResearch

  3. DATE: November 14, 2026 at 11:31PM
    SOURCE: SCIENCE DAILY PSYCHOLOGY FEED

    TITLE: Alzheimer’s may start shrinking two brain regions years before memory loss

    URL: sciencedaily.com/releases/2026

    Johns Hopkins scientists have uncovered hidden warning signs of Alzheimer’s disease that may appear up to a decade before memory loss begins. Brain scans revealed that two regions involved in memory and emotion start shrinking before the hippocampus, the area doctors typically examine for signs of Alzheimer’s. These early changes are linked to abnormal tau protein buildup and could provide a powerful new way to identify people at risk.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Alzheimers #AlzheimersResearch #BrainHealth #DementiaAwareness #MemoryLoss #Neuroscience #BrainResearch #EarlyDetection #TauProtein #MedicalResearch

  4. DATE: November 14, 2026 at 11:31PM
    SOURCE: SCIENCE DAILY PSYCHIATIRY FEED

    TITLE: Alzheimer’s may start shrinking two brain regions years before memory loss

    URL: sciencedaily.com/releases/2026

    Johns Hopkins scientists have uncovered hidden warning signs of Alzheimer’s disease that may appear up to a decade before memory loss begins. Brain scans revealed that two regions involved in memory and emotion start shrinking before the hippocampus, the area doctors typically examine for signs of Alzheimer’s. These early changes are linked to abnormal tau protein buildup and could provide a powerful new way to identify people at risk.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Alzheimers #AlzheimersResearch #BrainHealth #EarlyDetection #DementiaAwareness #Neuroscience #MedicalResearch #MemoryLoss #TauProtein #HealthNews

  5. DATE: November 14, 2026 at 11:31PM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Alzheimer’s may start shrinking two brain regions years before memory loss

    URL: sciencedaily.com/releases/2026

    Johns Hopkins scientists have uncovered hidden warning signs of Alzheimer’s disease that may appear up to a decade before memory loss begins. Brain scans revealed that two regions involved in memory and emotion start shrinking before the hippocampus, the area doctors typically examine for signs of Alzheimer’s. These early changes are linked to abnormal tau protein buildup and could provide a powerful new way to identify people at risk.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Alzheimers #AlzheimersResearch #BrainHealth #DementiaAwareness #MemoryLoss #Neuroscience #MedicalResearch #EarlyDetection #TauProtein #BrainScience

  6. Attention by Wayne Wu, 2024

    Wayne Wu’s Attention was the first book to provide a systematic overview and assessment of different empirical and philosophical works on attention. In this revised and expanded second edition Wu discusses the following central topics and problems: the nature of attention and the structure of the theory of attention...

    #books
    #nonfiction
    #neuroscience
    #psychology
    #attention
    #Routledge

  7. Can you make a call faster than a crow? Statistically, probably not. On average, crows can make a decision within 235 milliseconds; we take twice as long.

    Link: science.org/doi/10.1126/scienc

  8. DATE: November 14, 2026 at 10:00AM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: New case study offers causal evidence linking the right amygdala to PTSD

    URL: psypost.org/new-case-study-off

    In a rare clinical case involving a man with drug-resistant epilepsy and severe post-traumatic stress disorder (PTSD), selectively inactivating part of his right amygdala reduced his tendency to perceive ambiguous faces as fearful and was followed by a sharp drop in trauma symptoms. Published in Nature Communications, the study tracked brain signals and emotion perception before and immediately after the awake bedside procedure. Although drawn from a single patient, the findings offer unusual causal evidence that right-amygdala activity helps sustain threat-focused biases and PTSD symptoms.

    Threat bias and the amygdala in PTSD

    PTSD is a psychiatric condition that can develop after severe trauma, marked by intrusive memories, avoidance of trauma reminders, negative shifts in mood and thinking, and persistent physical jumpiness. A central feature of the disorder is negative interpretation bias, the tendency to read neutral or ambiguous cues, such as an unreadable facial expression, as threatening. Seeing everyday surroundings as dangerous keeps fear responses active and makes emotions harder to regulate.

    Research into this threat bias often focuses on the amygdala, a pair of almond-shaped neuron clusters deep inside the brain’s left and right temporal lobes, roughly behind the temples. The amygdala helps detect danger and coordinate fear responses, and brain scans consistently show heightened amygdala reactivity to fearful or neutral sights in people with PTSD. Standard brain imaging, however, only captures correlations, leaving uncertain whether abnormal amygdala activity drives negative interpretation bias or merely accompanies it.

    Studying localized brain damage or targeted neurosurgery offers a rare way to observe what happens when amygdala function is directly disrupted. In people without PTSD, bilateral amygdala damage selectively dulls recognition of fearful faces while leaving happy-face recognition intact. Meanwhile, as the authors of a 2026 narrative review argued, patients treated for limbic epilepsy, where seizures arise in deep emotion and memory structures such as the amygdala and neighboring seahorse-shaped hippocampus, offer a clinical window for linking psychiatric symptoms to specific brain circuits.

    Pinpointing how to intervene in these deep brain circuits has been difficult without direct internal brain-wave markers or established targets for therapies that adjust neural activity. “There is a lack of validated biomarkers of intracranial activity that localize and monitor abnormal cognitive activity in PTSD,” senior study author Jon T. Willie, chief of functional and epilepsy surgery at the University of Texas at Austin’s Dell Medical School, told PsyPost. Willie also pointed to a “lack of understanding of lateralized functions of right versus left amygdala in PTSD” and a “lack of robustly validated therapeutic targets for surgery or neuromodulation for PTSD.”

    In a 2020 case series co-authored by Willie, laser ablation of both the right amygdala and adjacent hippocampus for epilepsy eased PTSD symptoms, leaving uncertain whether relief stemmed from disrupting the amygdala itself or from removing hippocampal tissue and stopping seizures. Led by first author Tao Xie alongside Willie and co-senior author Peter Brunner, the researchers studied a rare patient with epilepsy and chronic PTSD who underwent isolated right-amygdala ablation two months before hippocampal surgery, separating the amygdala’s role from seizure control. The ablation was performed primarily to control his seizures, with the PTSD outcomes tracked as a secondary question.

    Mapping emotion and ablating the right amygdala

    To perform that first-stage procedure, doctors used stereoelectroencephalography-guided radiofrequency ablation. Thin wire electrodes are implanted deep into the brain to record electrical activity and pinpoint seizure sources. High-frequency current then heats selected contacts to roughly 58 to 60 degrees Celsius, permanently inactivating a three- to seven-millimeter tissue zone while the patient stays awake.

    The patient was a 41-year-old man with typical intellectual ability, drug-resistant temporal lobe epilepsy, and severe PTSD from trauma during adolescence. For baseline comparison, the team recruited 16 temporal lobe epilepsy patients undergoing deep-brain electrode monitoring at the same hospital, none of whom had PTSD. The group included seven men and nine women, with an average age of 37. De-identified behavioral and brain-recording data and analysis code for the patient were posted publicly on the Open Science Framework.

    Seven electrode contacts were placed in the patient’s right amygdala and three in his left amygdala, alongside standard scalp electrodes. Early in hospitalization, antiseizure medications were briefly lowered to capture spontaneous right-hippocampus seizures, then fully restarted more than seven hours before testing began, with no seizures occurring during any task, stimulation, or ablation.

    Before the ablation, the patient completed 252 trials of a facial emotion discrimination task, while the 16 controls completed roughly 260 trials on average. Participants viewed faces for one second morphed from 0 percent fearful (fully happy) to 100 percent fearful, with 50 percent representing an ambiguous expression, then classified each face as fearful or happy and rated their confidence. Electrodes simultaneously recorded late-phase brain waves 350 to 650 milliseconds after each face appeared, reflecting sustained emotional processing.

    On the morning of the procedure, researchers mapped the patient’s amygdala by delivering one-second electrical pulses mixed randomly with sham trials across contact pairs in both hemispheres, asking him to report any physical or emotional sensations. That afternoon, doctors ablated tissue around five contacts in his right basal and lateral amygdala, and 20 minutes later he completed 336 trials of the face task.

    Immediate shifts in fear perception and brain activity

    Before ablation, the patient showed a marked negative interpretation bias compared with the 16 controls, judging ambiguous 50-percent faces as fearful notably more often. That difference reached statistical significance against the male controls but not the female controls. Group differences on happy faces were not statistically significant.

    Scalp and right lateral amygdala recordings likewise showed a strong gap in late-phase electrical responses between fearful and happy faces, with most of his right lateral amygdala contacts exceeding the 90th percentile of controls; corresponding differences in his left amygdala and in control patients’ amygdalae were not statistically significant.

    Pre-ablation electrical stimulation pointed to a similar left-right split. Mild currents of 1.5 to 2.0 milliamperes across three right-amygdala subregions reliably evoked tingling chills in his head, chest, and shoulder along with euphoria, whereas left-amygdala stimulation produced nothing up to 2.5 milliamperes and evoked a pleasant childhood memory at 3.0 milliamperes.

    Post-procedure MRI scans showed that the lesion inactivated 47 percent of the right amygdala while sparing more than 99.9 percent of the right hippocampus, with electrode recordings confirming that the targeted tissue had stopped producing normal electrical activity. Retested 20 minutes later, the patient judged ambiguous and moderately fearful faces as fearful much less often across all four blocks, matching controls on intermediate expressions. Changes on moderately happy faces were not statistically significant, though compared with controls he rated unmistakably happy faces as fearful substantially more often and unmistakably fearful faces less often.

    His decisions also slowed after ablation, with average reaction time rising from 0.7 to 1.1 seconds. He also grew less certain of his judgments overall, and his pre-ablation pattern of higher confidence when calling faces fearful than happy was no longer statistically significant.

    Neurally, the late-phase electrical gap between fearful and happy faces vanished across the right amygdala and nearby right-hemisphere areas. Meanwhile, a new distinction emerged in his intact left amygdala alongside smaller responses to ambiguous faces. The authors suggest that silencing overactive threat signals from the right amygdala may have shifted emotion networks toward slower, more deliberate evaluation involving the left amygdala.

    PTSD symptom relief independent of seizure control

    To track clinical outcomes beyond the hospital stay, the patient completed validated questionnaires measuring PTSD, anxiety, and depression symptoms before hospitalization and two months after right-amygdala ablation. At that two-month mark, his PTSD score fell from 50 (severe) to 21, well below the diagnostic cutoff of 31 to 33, with gains across intrusive memories, avoidance, negative mood, and hyperarousal, alongside milder drops in anxiety and depression. His seizure rate stayed unchanged at roughly 10 per month during those two months, dropping below one per month only after a second-stage laser surgery on his right hippocampus and neighboring entorhinal cortex. That stability indicates his PTSD relief was not a byproduct of seizure control, though he noticed less heart racing and milder warning auras during seizures.

    Notably, the patient was not undergoing structured talk therapy or taking PTSD-targeted psychiatric medications during the study period. “The remarkable result was evidence of immediate widespread changes in behavior, brain dynamics, and PTSD benefit without dependency on other traditional therapies such as medications or cognitive behavioral therapy,” Willie explained.

    These findings align with an earlier brain-circuit and neurostimulation study of war veterans, which examined focal brain injuries and non-invasive magnetic brain stimulation in veterans rather than surgical ablation in a single patient, and similarly found that dampening amygdala-linked pathways eased PTSD symptoms. They also complement an earlier functional MRI study of identical twins, which likewise linked heightened amygdala reactivity to threat-related processing of ambiguous facial expressions in PTSD. That earlier study, however, measured correlational brain activation across twins rather than behavioral and symptom changes after surgical ablation in one individual.

    “The novelty of the study is that this is the first clear demonstration of a specific causal role for the right amygdala in maintaining PTSD, indicating that therapies that reduce or block right amygdala could provide effective therapy for PTSD,” Willie said. At the same time, he noted that “this is an early feasibility study that could lead to future larger studies that target the right amygdala to treat PTSD.”

    Caveats and next steps for research

    There are a few things to keep in mind when interpreting these findings. The evidence comes from one patient whose brain circuits were shaped by years of drug-resistant epilepsy and antiseizure medications, so his neural organization may differ from that of most people with PTSD, and left-right amygdala specialization can vary across individuals.

    “Readers should be cautioned that amygdala ablation has not been sufficiently studied to offer this widely as a therapy for PTSD,” Willie emphasized. “Better understanding of mechanisms and larger prospective controlled clinical trials are required to know the safety, feasibility, and effectiveness of amygdala interventions in different patient populations.”

    Because awake neurosurgery cannot include a blinded sham procedure, expectations of relief, postoperative mood changes, or familiarity with repeating the face task 20 minutes after ablation may have influenced performance. In addition, the ablation slowed his judgments and shifted his ratings in opposite directions at both ends of the emotional continuum, suggesting that ablating amygdala tissue may blunt overall emotional calibration rather than removing threat bias alone.

    Because the patient underwent hippocampal surgery two months later, the researchers could not isolate the durability of right-amygdala ablation beyond two months, though he still reported PTSD relief a year later. Future studies with larger samples, longer follow-up, and reversible techniques such as focused ultrasound or targeted electrical stimulation are needed to test whether quieting the right amygdala can safely treat severe PTSD.

    To lay that groundwork, the team is investigating how the amygdala shapes the brain’s ability to recognize when a situation is safe rather than threatening. “Our next steps are to better define the mechanisms by which amygdala-focused interventions can be used to understand and treat PTSD,” Willie added. “We are studying neurosurgical epilepsy patients (in whom PTSD is also common) who undergo intracranial monitoring to understand basic mechanisms of fear and safety learning and how stimulation and ablation affect these processes and how this might be translated into therapies.”

    The study, “Right amygdala ablation reduces maladaptive negative interpretation bias and symptoms in a patient with post-traumatic stress disorder,” was authored by Tao Xie, Sanne J. H. van Rooij, Sai Sun, Noah K. Bryson, Phillip Demarest, Haeorum Park, Luigi Maccotta, Shuo Wang, Peter Brunner, and Jon T. Willie.

    URL: psypost.org/new-case-study-off

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PTSD #MentalHealth #Neuroscience #BrainResearch #Amygdala #TraumaRecovery #Psychology #ClinicalResearch #BrainHealth #MedicalResearch

  9. DATE: November 14, 2026 at 07:25AM
    SOURCE: SCIENCE DAILY PSYCHIATIRY FEED

    TITLE: Stanford scientists discover hidden brain signals that predict Alzheimer’s years before symptoms

    URL: sciencedaily.com/releases/2026

    Stanford researchers have discovered that hidden patterns of brain activity can predict Alzheimer’s risk years before memory problems appear, potentially offering an earlier warning than traditional biomarkers. The same patterns also reveal which brains are unusually resistant to aging, raising hopes for future treatments that could help protect memory.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Alzheimers #AlzheimersResearch #BrainHealth #Neuroscience #StanfordResearch #EarlyDetection #MemoryHealth #BrainScience #HealthyAging #MedicalResearch

  10. DATE: November 14, 2026 at 07:25AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Stanford scientists discover hidden brain signals that predict Alzheimer’s years before symptoms

    URL: sciencedaily.com/releases/2026

    Stanford researchers have discovered that hidden patterns of brain activity can predict Alzheimer’s risk years before memory problems appear, potentially offering an earlier warning than traditional biomarkers. The same patterns also reveal which brains are unusually resistant to aging, raising hopes for future treatments that could help protect memory.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Alzheimers #AlzheimersResearch #BrainHealth #Neuroscience #EarlyDetection #Memory #Aging #MedicalResearch #StanfordMedicine #HealthInnovation

  11. What if #AI could build neural networks without training them? Yet neural predictions across vision, language and audition.
    🧠 Interpretable Weight-Space Programming Builds Transparent Transformers and Brain Encoding Models
    📄 alphaxiv.org/abs/2611.interpre

    #Neuroscience #LLM

  12. My video about some general things regarding the human brain. I discuss the way our experiences shape our brains and how that in turn affects our behavior, and some important features of our brains. I end with an overview of the most important terminology used to orient inside the brain. That will be useful, if you want to study anatomy in more detail.
    youtu.be/s0Ky2g1m-qQ
    #psychology #anatomy #physiology #brain #neurology #neuroscience #cognition #mind #thinking #human

  13. CHLA researcher explores immune mechanisms behind rare pediatric neuroinflammatory diseases

    Her life-changing experience in hospitals as a child is part of what led Jesse M. Levine, MD, PhD,…
    #NewsBeep #News #Health #Brain #CA #Canada #MedicalResearch #Neuroimmunology #neurology #Neuroscience #pacemaker #research
    newsbeep.com/ca/969965/

  14. DATE: November 13, 2026 at 04:00PM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: Scientists built an AI called “Concept2Brain” that simulates human brain waves from pictures and text

    URL: psypost.org/scientists-built-a

    Scientists have developed an artificial intelligence tool called Concept2Brain that predicts how human brain waves respond to photographs or written text. In a study published in Nature Communications, the researchers report that the open-access platform generates synthetic electroencephalography (EEG) recordings that resemble real human brain activity during visual and emotional perception. The system could allow researchers to simulate brain-wave experiments on a computer before recruiting human volunteers.

    Electroencephalography, or EEG, uses sensors placed on the head to measure tiny electrical voltage changes at the scalp produced by brain activity. Because this technique tracks neural activity millisecond by millisecond, scientists often repeat an image or event many times and average the time-locked EEG traces to isolate event-related potentials, which are characteristic wave patterns tied to seeing, thinking, or feeling.

    In recent years, artificial intelligence has increasingly been paired with brain imaging to interpret what a person is experiencing. Much of that effort has focused on decoding, such as an fMRI study in which volunteers listened to stories, watched silent movies, or imagined narratives while a computer model reconstructed the general meaning of those stories from their brain scans.

    Far less attention has gone to the reverse problem, known as encoding, in which a computer starts with an image or phrase and predicts the fast-moving scalp electrical waves an observer would produce. To make such predictions possible, neuroscientists first built large reference libraries linking thousands of everyday object concepts to human brain activity, including a 2023 multimodal neuroimaging project that cataloged brain scans and similarity ratings across 1,854 object categories.

    Building on large visual datasets, a 2022 study showed that computer encoding models could simulate millisecond-by-millisecond EEG responses directly from object photographs. Other research has established that scalp electrical waves reflect not only what an object is, but also how emotionally intense it feels, including a 2008 EEG study co-authored by one of the same researchers that linked emotional arousal to the size of electrical brain responses.

    Because recording real EEG data from human participants is costly and time-consuming, Alejandro Santos-Mayo, then at the University of Florida and the Complutense University of Madrid, and his colleagues set out to create a generative tool that bridges conceptual meaning and scalp electrical activity. By connecting a brain-wave compression network with a multimodal AI system, the team aimed to capture complex, multi-variable patterns in brain waves and predict participant-specific EEG responses from both pictures and written descriptions.

    “The evolution of artificial intelligence (AI) tools has opened a new, non-linear, multivariate approach to analyzing and predicting brain data,” Santos-Mayo, the study’s lead author, now at NeuroSpin, a brain-imaging center at Université Paris-Saclay, and the Department of Psychology at the University of Florida, and author of Emociones con sentido, told PsyPost. “A fundamental objective of science is not merely to observe nature, but to understand it—and understanding any phenomenon requires being able to predict it.”

    “Here, we aimed to create a new tool for predicting electroencephalography (EEG) brain signals,” he said. “By predicting these signals, we can generate synthetic EEG samples without relying on slow, costly data collection, while gaining a deeper understanding of how different neurophysiological components manifest in the brain. The ultimate goal of Concept2Brain is to offer a free, open-access tool for anyone interested in simulating EEG activity.”

    To train Concept2Brain, the researchers used EEG recordings from two earlier passive picture-viewing experiments conducted by members of the same research group, encompassing 88 university volunteers receiving course credit. In the first experiment, 45 participants viewed 120 naturalistic photographs twice for one second each against a black background, while in the second, 43 participants viewed 240 different photographs once for two seconds each against a gray background.

    Across both datasets, the 360 unique photographs were divided evenly among pleasant, neutral, and unpleasant scenes, and varying the screen layouts was intended to keep the model focused on picture content rather than visual borders. Brain activity was recorded from 128 scalp sensors plus a reference sensor at 500 samples per second, providing 13,640 clean 1.5-second trials after filtering out blinks and movement noise.

    Concept2Brain links two deep neural networks to convert real-world concepts into brain waves. The first network, called a conditional variational autoencoder, compresses each 129-channel EEG recording into a compact summary of 256 numbers while tagging the recording with a participant identifier so it preserves individual differences in brain-wave shape. Once trained, the decoder half of this network can turn any 256-number summary back into a smooth, trial-averaged EEG pattern for any of the 88 virtual participants.

    The second network serves as a translator built around OpenAI’s CLIP system, an existing AI model that maps both pictures and written words into a shared 512-number conceptual space. A three-layer neural network learns to translate those conceptual numbers into the 256-number brain-wave summary, enabling users on the public Concept2Brain website to upload an image or type text and download simulated brain responses. The authors also posted the model’s code, trained weights, and underlying EEG datasets in public repositories.

    “I would like to invite readers to try the model for themselves,” Santos-Mayo said. “Our primary goal has always been to create an open, accessible tool for everyone, which is why we developed the online platform at concept2brain.brainbodybehavior.science. No installation is required, and the model can be run directly in your browser.”

    To test how well the system worked, the team first ran a 10-round cross-validation check, repeatedly training the model on 80 percent of the photographs, monitoring overfitting on 10 percent, and predicting brain waves for the remaining 10 percent held out of training. They also tested whether the system reproduced classic wave landmarks, rhythmic brain oscillations, and individual participant traits, and evaluated it against independent public brain-imaging datasets and written text prompts.

    When predicting responses to held-out photographs, Concept2Brain produced synthetic brain waves that closely matched real human recordings across most images, with alignment emerging around 100 milliseconds after picture onset, when visual signals reach the cortex, and remaining strong until roughly 700 milliseconds. One notable exception was an erotic photograph that showed a negative correlation with the real brain data, which the authors suggest may have occurred because CLIP’s built-in content-safety guardrails distorted how that image was represented.

    When fed the 360 photographs it had been trained on, the model’s simulated waveforms closely tracked the empirical recordings across all scalp sensors and time points, reproducing early visual waves as well as the late positive potential, a slow wave over parietal sensors between 400 and 800 milliseconds linked to emotional engagement. The synthetic data also reproduced rhythmic brain changes, such as a drop in 10-hertz alpha waves after 300 milliseconds, and matched each of the 88 virtual participants most closely to their own real-world human counterpart.

    Next, the researchers tested Concept2Brain on 1,078 emotional photographs from a standardized picture library that were not included in training, finding a modest positive association between the size of the simulated late positive potential and standard human ratings of emotional arousal. When given photographs of fearful and neutral expressions from 140 actors in a facial-expression database, the model also generated larger face-processing waves around 170 to 200 milliseconds and larger late emotional waves for fearful faces than for neutral faces, even though it had never been trained on facial-expression labels.

    To check whether predictions generalized to other laboratories, the team tested Concept2Brain against an external multimodal dataset of everyday objects. In that dataset, 4 volunteers viewed 1,854 object concepts during magnetoencephalography, which records the tiny magnetic fields produced by brain activity, and 3 volunteers viewed 720 object concepts during functional MRI. Concept2Brain’s synthetic waves aligned with early visual and later semantic phases in the magnetic recordings, and correlated with functional MRI activity in early visual cortex around 75 milliseconds and in a face-processing region around 190 milliseconds.

    In a second external test, the researchers entered stimuli from an independent EEG dataset of 40 people viewing 40 faces and 40 cars. Concept2Brain reproduced the spatial scalp map distinguishing faces from cars, though the authors note that overall associations across both external datasets were weaker than within-dataset tests.

    “The model was trained in an entirely unsupervised manner—we never explicitly labeled the visual content of the images used during training,” Santos-Mayo noted. “One of the first pleasant surprises was the model’s ability to simulate synthetic EEG signals for images containing faces.”

    In brain research, the face-processing region from the fMRI comparison is known as the right fusiform face area, and its rapid electrical signature is called the N170 component. “We know from existing literature that facial stimuli activate the right fusiform face area around 170 ms (the N170 component),” he said. “Despite the unsupervised setup, the model spontaneously and accurately reproduced this 170 ms component.”

    Because CLIP handles both images and text, the researchers also tested Concept2Brain with 120 short written descriptions sorted into pleasant, neutral, and unpleasant categories, as well as short example prompts such as “a picture of an alligator.” Across all 88 virtual participants, pleasant and unpleasant descriptions prompted larger late emotional waves between 400 and 800 milliseconds than neutral descriptions.

    As an illustration using just two statements about climate change, the model also produced stronger simulated brain responses to a statement emphasizing harmful consequences than to one describing mitigation strategies. The authors note that this pattern is consistent with negativity bias, the tendency for negative information to draw a stronger response. The paper reports the emotion, face, and text comparisons descriptively, without formal statistical tests.

    “Another major surprise involved using written text to test the model,” Santos-Mayo added. “By leveraging CLIP—an OpenAI network capable of processing both images and text—we tested Concept2Brain’s performance using simple written descriptions instead of visual images. The resulting performance was remarkably similar to that achieved with real pictures, highlighting that our model opens a promising avenue for cross-modal brain signal generation.”

    “From a cognitive neuroscience perspective, one of the key findings of Concept2Brain is the suitability of conditioned variational autoencoders (cVAEs)—a type of AI architecture—for analyzing and extracting the non-linear latent space of EEG data,” he explained. “The use of these advanced methods needs to become more widespread in our field. Outside our discipline, the average reader can view the Concept2Brain model as an exciting milestone in brain data simulation. Despite the current limitations of the model, this work marks the beginning of a new era in using AI techniques not only to observe the brain, but also to generate synthetic reproductions of its signals.”

    There are a few important things to keep in mind when interpreting these simulations. Although Concept2Brain accepts written prompts, the model was trained exclusively on brain recordings from people viewing photographs rather than reading sentences, meaning text inputs estimate how a brain might respond to a related visual concept rather than simulating actual language comprehension. The authors caution that text-prompted predictions are less validated and may be noisier than picture-based outputs.

    “While this model demonstrates the ability of AI to predict and simulate brain signals, users must interpret synthetic data with caution,” Santos-Mayo cautioned. “Synthetic data cannot replace empirical data collected from human participants, nor can it be used to draw definitive scientific conclusions. Instead, its purpose is to provide a fast method for testing hypotheses or estimating sample sizes prior to real-world data collection.”

    “The current version of Concept2Brain was trained on 88 human participants across 360 distinct images,” he said. “This sample size established the viability of the AI architecture, though future iterations will require larger datasets to achieve higher fidelity.”

    In addition, Concept2Brain produces smoothed waveforms that resemble averages across many repeated trials, so it cannot capture the trial-to-trial variability of raw single EEG recordings or model underlying cellular mechanisms. Its correspondence with real brain activity also weakened when tested against external datasets collected with different recording hardware and tasks.

    “It is natural to feel apprehensive about rapid AI advances, especially when they touch on something as personal and complex as the human brain. However, I want to clarify that this model cannot replace a real human brain, nor can it generate a synthetic ‘brain-like’ mind. The current state of the field is nowhere near that capability,” Santos-Mayo emphasized.

    “Developing such a model would require virtually impossible amounts of data from a single individual, with no guarantee of success,” he added. “Concept2Brain makes much more modest claims: it serves as a solid proof of concept and a technical milestone in brain signal simulation, but it poses no threat to society, nor should it trigger dystopian fears.”

    Finally, the current model learned its concept-to-brain mapping from 88 volunteers viewing 360 photographs, which limits both the diversity of virtual brains and the range of visual concepts it represents. Because the current architecture depends on OpenAI’s CLIP to interpret stimuli, any blind spots, biases, or content filters inside that third-party system can carry into the generated brain waves, though the authors designed the framework so CLIP can be swapped out for newer AI models in future versions.

    “This research opens new horizons not only for predicting brain signals, but also for enhancing our broader toolkit in cognitive neuroscience,” Santos-Mayo shared. “Currently, I am working on developing new non-linear methods based on neural networks to decode brain activity. Concept2Brain proved the suitability of cVAE architectures for extracting the latent dimensionality of EEG signals—meaning we can isolate and distill pure informational features from raw brain activity to interpret, understand, and predict cognitive variables. I am now applying similar methods to other cognitive functions and building new tools for the research community.”

    “Regarding Concept2Brain specifically, we plan to release future upgrades trained on larger datasets incorporating more human participants, diverse stimulus samples, additional neuroimaging modalities, and updated AI components,” he continued. “We warmly welcome any researchers interested in collaborating on future versions.”

    The study, “Concept2Brain: an AI model for predicting neurophysiological responses to text and pictures,” was authored by Alejandro Santos-Mayo, Faith Gilbert, Arash Mirifar, Anna-Lena Tebbe, Ruogu Fang, Mingzhou Ding, and Andreas Keil.

    URL: psypost.org/scientists-built-a

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #ArtificialIntelligence #AIResearch #Neuroscience #BrainWaves #EEG #BrainScience #MachineLearning #CognitiveNeuroscience #Neurotechnology #ScienceNews

  15. DATE: November 13, 2026 at 03:22PM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: Screens, inherited childhood scripts, and therapy skepticism lead this week’s psychology podcasts

    URL: psypost.org/screens-inherited-

    Can you reset your brain’s reward system by unplugging for a day? One clinical psychologist argued in a rebroadcast this week that you can’t, while an addiction psychiatrist made the case for a month-long abstinence “experiment.” The two positions are not identical, but they pull in different directions on a question many listeners are asking about their phones and habits. Across 19 episodes from 13 shows, that conversation about dopamine sat alongside two other recurring threads: whether consciousness can be explained by the brain at all, and how childhood “scripts” carry into adult life.

    The week’s other notable discussions include Scott Galloway putting his claim that therapy has been oversold to a psychologist, a neuroscientist explaining a theory that treats experience itself as the starting point, and a live panel making the case that fun deserves to be taken seriously.

    Desire, Dopamine and Addiction

    All In The Mind rebroadcast “Dopamine, detoxes and donuts”, in which clinical psychologist Dr Anastasia Hronis, author of The Dopamine Brain, explains what dopamine does for motivation, movement and behaviour. She discusses how technology platforms keep users engaged. She also argues that trendy 24-hour detoxes and “raw dogging” flights cannot reset a chemical the brain depends on.

    On Huberman Lab, Stanford addiction psychiatrist Dr. Anna Lembke appears in “Overcome Addictions & Obsessions of All Kinds”. The long conversation covers her pleasure-pain balance model, digital media addiction among adolescents, and her argument for a 30-day abstinence period. A large part of the conversation turns to the subject of her new book, Radical Surrender: letting go of the need for control. Listeners interested in the detox debate may want to hear both episodes back to back.

    What Consciousness Is

    On Human Potential Lab, neuroscientist Christof Koch tells Scott Barry Kaufman that “Consciousness Isn’t in the Brain”. He explains Integrated Information Theory and argues that today’s AI systems could be intelligent without feeling anything. The conversation covers efforts to detect consciousness in unresponsive patients, and Koch describes how mystical experiences, including his own near-death experience, led him to take seriously the idea that consciousness is fundamental to reality. He admits that view is hard to reconcile with IIT.

    A related but more philosophical angle comes from Modern Wisdom‘s “Why Atheists Keep Finding God (in everything)”. In this episode, mostly about religion and prayer, writer Alex O’Connor argues that consciousness is the biggest gap in materialism and “basically every worldview.”

    In a Huberman Lab Essentials episode, “How Emotions & Social Factors Impact Learning”, USC’s Dr. Mary Helen Immordino-Yang discusses how emotions, stories and culture shape learning and the self. She illustrates emotional development with her young daughter’s changing descriptions of love.

    The Scripts We Inherit

    A short Diary Of A CEO clip, “Most Replayed Moment: The Childhood Scripts Still Running Your Life! Chase Hughes”, features a former Navy behavior expert. He claims that what people call authenticity is a “costume” of childhood beliefs, and he offers exercises for loosening them.

    The same show’s “How Did A Homeless 13-Year-Old Become Comedy’s Most Fearless Voice?” is mostly about Katt Williams’s life and career. Part of it turns to how early family dynamics shape relationships, with Steven Bartlett reflecting on his own avoidant tendencies.

    Rapper Bugzy Malone’s Modern Wisdom episode, “How To Turn Your Pain Into Greatness”, centers on his music career. It also explores how children absorb family dysfunction and why people discredit successful peers.

    On Where Should We Begin?, Esther Perel works with a couple separating after nearly 40 years while remaining legally married. In “I’ll Still Be Your Financial Partner, But I’m Done Being Your Wife”, she explores the enmeshment beneath their apparent differences.

    Connection, Fun and Feeling

    Organizational psychologist Adam Grant joins The Rich Roll Podcast for “Adam Grant On The Secrets Of Strong Relationships In A Lonely World”. The conversation covers his new book on human connection, including how screens offer a facsimile of it.

    The Happiness Lab‘s live Aspen session, “Are You Taking Fun Seriously Enough?”, pairs journalist Catherine Price and psychologist Elizabeth Dunn. They discuss research on what makes days feel good, and Price distinguishes true flow from the “junk flow” of binge-watching.

    On Speaking of Psychology, social psychologist Tim Wildschut explains in “Why nostalgia is good for you” how research has recast nostalgia as a largely beneficial emotion. He also notes the conditions under which it isn’t.

    Sex and Psychology Podcast host Justin Lehmiller and coach Shelby Devlin address “What People Get Wrong About Dominance and Submission”. They contrast media portrayals of kink with the consent and communication real power exchange requires, and they discuss how abusers can misuse its language.

    Therapy, Belief and Society

    The Prof G Pod‘s “Is Therapy Overrated?” has Scott Galloway testing his essay “The Cult of Therapy” with Dr. Jonathan Shedler, a UCSF clinical psychologist known for research on the effectiveness of psychodynamic therapy, who agrees with much of the critique. The same show’s “Your Parents’ Wealth Matters More Than Your Salary”, with historian Eliza Filby, author of Inheritocracy, is mainly about inheritance and inequality. One segment examines the “financial nihilism” of anxious young adults.

    On The Joe Rogan Experience, actor Gary Sinise’s episode (#2579) covers his career and USO tours. Several segments address veterans’ mental health, with Rogan skeptical of counseling and medication.

    Comedian Jordan Klepper joins StarTalk for “Cosmic Queries – Curiosity, Conspiracies & the God Particle”. This fan-question episode includes segments on curiosity, certainty and cognitive biases, with Neil deGrasse Tyson describing how he nudges flat-Earth believers back toward curiosity.

    Brain Health

    In Diary Of A CEO‘s “What Are The Five Lifestyle Habits Destroying Your Brain Right Now?”, neurologist Dr. David Perlmutter argues that dementias are largely preventable metabolic conditions. A StarTalk episode with biomedical scientist Rhonda Patrick, “The Longevity Playbook”, released early to subscribers this week, focuses on healthspan, diets and exercise and includes a shorter brain-related segment.

    Childhood came up repeatedly this week, from Hughes’s scripts to Bartlett’s attachment reflections to Malone’s account of absorbing family dysfunction. These were mostly framed through personal story and self-help rather than research. The skepticism about therapy voiced on both Prof G and Rogan, arriving from very different directions, is also worth listening for.

    URL: psypost.org/screens-inherited-

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Psychology #PsychologyPodcasts #MentalHealth #ChildhoodTrauma #Therapy #Dopamine #AddictionRecovery #Consciousness #Neuroscience #PersonalGrowth

Share on Mastodon

Enter the server where you have an account.